Back to search results

Collection and Distribution of Biospecimens for Novel Research Uses

This observational study, called "Collection and Distribution of Biospecimens for Novel Research Uses," aims to gather and share biological samples (like blood or tissue) from people with various conditions, including cancer, autoimmune diseases, and infectious diseases, as well as healthy individuals. These samples will be used by researchers to discover new biomarkers (indicators of disease), develop new diagnostic tests and treatments, and for educational purposes. The study is looking for up to 10,000 participants aged 1 month to 89 years old. The main goal is to collect these biospecimens over a period of 10 years to support a wide range of medical research.

Study design
This is an observational study with a planned enrollment of 10,000 participants. It is not a treatment study, but rather focuses on collecting biological samples.
What's involved
If you participate, you may be asked to provide biospecimens, which could involve a blood collection or other samples. Your health will be assessed by medical staff through record review or a clinical exam.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for this study is the collection of biospecimens over a period of 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03848962

Collection and Distribution of Biospecimens for Novel Research Uses

Recruiting
Not specifiedAges 1–89Observational
iSpecimen Inc
~10,000 participants
Updated 2022-11-09 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Collection of Biospecimens for Novel Research Uses
Measured over 10 years

Conditions

Cancer
Healthy
Gastrointestinal Complication
Autoimmune Diseases
Infectious Disease
Women's Health: High-Risk Pregnancy
Dermatologic Disease
Blood Disease

Explore related trials

Autoimmune DiseaseDigestive System ComplicationDisorder of cellular component of bloodHealthyHigh Risk PregnancyInfectious DisorderMalignant NeoplasmSkin Disorder

Where it's being run

2 sites across 2 states
Alabama1
Massachusetts1

Who to contact

Emily L Hubbard
[email protected]
2567970003
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Individual is developmentally aged 7 years old and above for RUO collections (only)
Individual meets requirements of a current request for research materials from iSpecimen
If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant
Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf.
Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf

What this trial measures

  • Collection of Biospecimens for Novel Research Uses10 years

    Repository of diseased and healthy tissue, blood derivatives and related biological specimens